Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...

Prof. Nicolas Barry-Delongchamps, Professor of Urology at Cochin Hospital and Principal Investigator of the VIOLETTE trial, will present the final results and one-year patients follow-up from the ...

High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively), a ...

Testosterone Therapy for Severe Hypogonadism Improves Sexual Function In patients undergoing confirmatory biopsy for active surveillance, MRI can increase detection of clinically significant tumors ...

MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...

A trial found no meaningful difference in detection of clinically significantly prostate cancer between multiparametric MRI-based and microultrasound-based biopsy techniques.

September is National Prostate Cancer Awareness Month, an important time to bring awareness to prostate health. The prostate gland is a male reproductive organ about the size of a ping-pong ball that ...

Here's welcome news for men of a certain age: new results support a less invasive approach to investigations for suspicion of prostate cancer. An approach using MRI of the prostate followed by ...

Excluding systematic biopsy in favor of MRI-targeted biopsy in men with elevated prostate-specific antigen (PSA) levels reduced the probability of detecting clinically insignificant cancers, but at ...

Microultrasonography-guided prostate biopsy proved noninferior to MRI/conventional ultrasound-fusion (MRI/US-fusion) imaging for detecting clinically significant cancer, a large randomized trial ...